AzTrials
AzTrials

Hip OsteoarthritisNCT05108155

Regression Discontinuity Design Search for Differences in Mortality and Revision for Fixation Type of THA

An observational study of Hip Osteoarthritis, run by Leiden University Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to apply the regression discontinuity design (RD) methodology on arthroplasty registry data. The investigators aim to use an age-based cut-off for fixation type choice and estimate the causal effect of fixation type on short term mortality and revision, using a fuzzy regression discontinuity… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hip Osteoarthritis
What is being tested?
Cemented THA and Unemented THA
Type of treatment
Surgery or procedure
How many people
43,789 participants
Where
1 siteNetherlands
Study dates
Jan 2007to Dec 2019
How long will I take part?
2 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The data will consist of all the THAs done in the aforementioned period in the 94 hospitals who report to the Dutch Arthroplasty Register.

Who may be able to join

  • Primary total hip arthroplasty with diagnosis osteoarthritis.
  • Placed January 1st 2007 and December 31th 2017
  • Patients who are 18 years and older

Who cannot join

  • Hybrid fixation type (cemented stem and uncemented acetabular component)
  • Reverse hybrid fixation type (uncemented stem and cemented acetabular component)
  • Metal-on-metal bearing THA

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Leiden University Medical Cente

    Leiden, South Holland

Other trials in Netherlands

About this study

Official title: Age-based Cut-off Point as Methodological Approach in Search for Differences in Mortality and Revision for Fixation Type: Cemented Versus Uncemented Total Hip Arthroplasty

The goal of this study is to apply the regression discontinuity design (RD) methodology on arthroplasty registry data. The investigators aim to use an age-based cut-off for fixation type choice and estimate the causal effect of fixation type on short term mortality and revision, using a fuzzy regression discontinuity design.

Read the detailed description

The optimal method of fixation for primary total hip arthroplasty (THA), cemented or uncemented remains unknown. Studying implant survival in both RCT and retrospective study design, as measured by the revision rate both gives inconclusive evidence, largely due to heterogeneity between patient groups. A network meta-analysis showed similar survival of newer uncemented implants compared to the traditional cemented hip implants. In general, older patients more frequently have cemented THAs. However, since these elderly patients have more comorbidity and might pass away or might be unfit for revision surgery, the likelihood of revision will be lower compared with younger patients with an uncemented THAs.

In the last decade, there is a trend towards an increased use of uncemented implants in Europe, Australia and the United States. This despite the fact that registry data show not unequivocal superior outcomes of these uncemented stems. One of the most important methodological challenges in observational data, is to determine whether the medical intervention under study is causally related to an outcome, rather than simply being correlated with another factor that is truly causally related to the outcome under study. This is a particular threat as in observational studies comparison groups are typically different in more aspects than just treatment type because of non-random treatment allocation. Patients are treated in accordance with the preferences of treating physicians, rather than because of a coin flip, like in randomized studies. These treatment choices are frequently informed by a patient's severity of illness. The treatment may be associated with outcome but could be interfered by other factors like disease severity that are causally related to outcome. Thus, observational studies assessing the causal effect of treatments are at risk of obtaining incorrect results. This type of bias is called confounding by indication. Since overall registry data are prone to inclusion bias and the aforementioned confounding by indication, a randomised controlled trial (RCT) design to analyse the difference in revision rate between these two THA fixation methods could clarify this unanswered question. RCTs are the best scientific method for evaluating the efficacy of treatment. However, randomised controlled trials may have poor external validity due to exclusion of patients not meeting the inclusion criteria. Therefore, complementing any evidence on treatment efficacy from randomised controlled trials with that from observational studies is valuable. When looking at implant survival an RCT design is also impractical due to the relatively long time until revisions (with the risk of revision is as low as 0.5 percent per year for the first 20 years) occur and thus a large number of patients needed, to correct for the heterogeneity between these patients. Furthermore, studying data from the Dutch Arthroplasty Registry (LROI), it shows a large variation in clinical practice of type of fixation of hip and cup stems between hospitals. When using data from a national registry with high completeness and hospital coverage, such as the LROI, regardless of age, confounding by indication exists (e.g. large variation in the selection of fixation type) and the patient group will be very heterogeneous. Thus, new research methods are warranted to isolate the effect of fixation of THA on outcome within registries.

Some orthopaedic surgeons and hospitals use an age-based cut-off in the choice for the type of fixation of components of the THA. The existence of such simple age-based cut-off guidelines for choosing for either a cemented or non-cemented stem and/or cup between different hospitals, enables us to analyse the causal effect of fixation on revision in THA. In one of the hospitals in the LROI it is known which age dependent cut-off points are used. In male patients above the age of 70 years old cement fixation is used, and under the cut-off age an uncemented THA is placed. In female patients this cut-off age is set at 65 years of age. This age-based cut-off point for assignment of either cemented or uncemented THA offers the opportunity for a new quasi-experimental research design while limiting the potential for selection bias, and allowing causal inference, namely the regression discontinuity design (RD). The RD is a quasi-experimental study design that was first introduced by psychologists Thistlethwaite and Campbell, who used the RD to evaluate the impact of National Merit Scholarship awards on awardees' careers and attitudes. Since then RD has also been applied in politics, psychology, and other areas, but a recent study showed it is underutilized in medicine.

The RD identifies causal effects by exploiting a treatment assignment practice: the assignment of treatment based on whether a patient scores above or below a cut-off point on a continuously measured variable, such as blood pressure, cholesterol, CD4 count or in our case age. Treatment assignment following such a rule can be either deterministic (every patient on the one side of the cut-off value receives the treatment and every patient on the other side does not) or probabilistic (the probability of receiving the treatment is higher on the one side of the cut-off value than on the other side). The first case is called ''sharp'' RD design (SRD) and the second ''fuzzy'' RD design (FRD).

The goal of this study is to apply the regression discontinuity design (RD) methodology on arthroplasty registry data. The investigators aim to use an age-based cut-off for fixation type choice and estimate the causal effect of fixation type on short term mortality and revision, using a fuzzy regression discontinuity design.

Being tested
Cemented THA, Unemented THA
Keywords
Total Hip Arthorplasty, Fixation, Cemented, Uncemented, Regression discontinuity
Medical subject headings
Osteoarthritis, Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cemented THAProcedure or surgery

    THA with cement fixation

  • Unemented THAProcedure or surgery

    THA with uncemented / pressfit fixation

Study groups in NCT05108155
Study groupRoleWhat they receive
THAPatient with primary total hip arthroplasty
Receives: Procedure: Cemented THA; Procedure: Unemented THA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants who die within 90 days after surgery

    Mortality after surgery

    Measured: 90 days

  2. Number of Participants who undergo revision surgery of the treated hip

    Number of Participants who undergo revision surgery of the treated hip as recorded in the LROI database.

    Measured: 2 years

Secondary outcomes (1)
  1. Number of Participants who undergo revision surgery of the treated hip

    Number of Participants who undergo revision surgery of the treated hip as recorded in the LROI database.

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2021
  2. Study startJan 2007
  3. Primary completionDec 2019
  4. Study completionDec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
43,789 participants (actual)
Target duration
2 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT05108155
Sponsor's protocol ID
17011991
Status last verified
Nov 2021
First submitted
3 May 2021
Last updated
15 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Abdulkarim A, Ellanti P, Motterlini N, Fahey T, O'Byrne JM. Cemented versus uncemented fixation in total hip replacement: a systematic review and meta-analysis of randomized controlled trials. Orthop Rev (Pavia). 2013 Mar 15;5(1):e8. doi: 10.4081/or.2013.e8. Print 2013 Feb 22.

    PubMed 23705066
  • Maloney WJ. National Joint Replacement Registries: has the time come? J Bone Joint Surg Am. 2001 Oct;83(10):1582-5. doi: 10.2106/00004623-200110000-00020. No abstract available.

    PubMed 11679613
  • Corbett KL, Losina E, Nti AA, Prokopetz JJ, Katz JN. Population-based rates of revision of primary total hip arthroplasty: a systematic review. PLoS One. 2010 Oct 20;5(10):e13520. doi: 10.1371/journal.pone.0013520.

    PubMed 20976011
  • Laupacis A, Bourne R, Rorabeck C, Feeny D, Tugwell P, Wong C. Comparison of total hip arthroplasty performed with and without cement : a randomized trial. J Bone Joint Surg Am. 2002 Oct;84(10):1823-8. doi: 10.2106/00004623-200210000-00013.

    PubMed 12377914
  • Makela KT, Matilainen M, Pulkkinen P, Fenstad AM, Havelin L, Engesaeter L, Furnes O, Pedersen AB, Overgaard S, Karrholm J, Malchau H, Garellick G, Ranstam J, Eskelinen A. Failure rate of cemented and uncemented total hip replacements: register study of combined Nordic database of four nations. BMJ. 2014 Jan 13;348:f7592. doi: 10.1136/bmj.f7592.

    PubMed 24418635
  • Pringle M, Churchill R. Randomised controlled trials in general practice. BMJ. 1995 Nov 25;311(7017):1382-3. doi: 10.1136/bmj.311.7017.1382. No abstract available.

    PubMed 8520259
  • Trochim WM, Cappelleri JC. Cutoff assignment strategies for enhancing randomized clinical trials. Control Clin Trials. 1992 Jun;13(3):190-212. doi: 10.1016/0197-2456(92)90003-i.

    PubMed 1320557
  • Steiner PM, Kim Y, Hall CE, Su D. Graphical Models for Quasi-experimental Designs. Sociol Methods Res. 2017 Mar;46(2):155-188. doi: 10.1177/0049124115582272. Epub 2015 May 14.

    PubMed 30174355
  • Moscoe E, Bor J, Barnighausen T. Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice. J Clin Epidemiol. 2015 Feb;68(2):122-33. doi: 10.1016/j.jclinepi.2014.06.021.

    PubMed 25579639

Questions about this trial

What is this clinical trial studying?

An observational study of Hip Osteoarthritis, run by Leiden University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants who die within 90 days after surgery (time frame: 90 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05108155, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2021; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in